Grey Cloak Tech, Inc. (OTCQB: GRCK) this morning announced its entry into a strategic partnership with Canbiola, Inc. (OTC: CANB) related to the listing of Canbiola’s products on Grey Cloak’s CBD.co marketplace. To kick off the relationship, Grey Cloak CEO Patrick Stiles interviewed Marco Alfonsi, CEO of Canbiola, and Dr. Robert Kornfield, medical advisory board member, regarding the partnership and Canbiola’s portfolio of products. The interviews, which are part of CBD.co’s new CBD TV initiative, are available for review at http://cnw.fm/2u6Iz. “Canbiola is the exact type of brand we want on the CBD.co marketplace,” Stiles stated in the news release. “They are a premier brand with unique proprietary technology. I’m sure our customers will love their products.”
To view the full press release, visit http://cnw.fm/STn1G
About Grey Cloak Tech Inc.
Grey Cloak Tech (OTCQB: GRCK) is the parent company of CBD.co as well as Eqova Life Sciences, which is a practitioner line of CBD products sold exclusively to licensed medical professionals. For more information, visit the company’s website at www.GreyCloakTech.com
More from CannabisNewsBreaks
About CBDWire
CBDWire (CBDW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CBDNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CBDW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CBDW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CBDW brings its clients unparalleled visibility, recognition and brand awareness. CBDW is where news, content and information converge.
For more information please visit https://www.cbdwire.com
Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer
CBDWire (CBDW)
Denver, Colorado
cbdwire.com
303.498.7722 Office
[email protected]
